Recursion’s Q3 2026 earnings call highlighted REC-4881 FAP data, REC-1245 tumor responses, $749 million in pro forma cash and ...

Tencent Hyra 2.0 AI research agent launched Monday claiming to train protein models, optimize quantum error-correction codes, and build reusable scientific tools autonomously - while feeding its ...

Do you ever get lost in your head while trying to follow recursive problems?In the autumn of 2025, a junior colleague asked ...

Revenue increase driven primarily by Sanofi collaboration, including a $10.0 million milestone for an immunology small molecule program R&D expense decreased mainly due to non-recurrence of $22.8 ...

Recursion (Nasdaq: RXRX), a leading clinical-stage company pioneering AI-enabled drug discovery and development, today announced that its Board of Directors has appointed Fred Hassan as Chair, ...

Although outside attention on Monday focused more on Anthropic’s latest financial data disclosed in its revised S-1A ...

Recursion will present REC-4881 data with specialist and patient panels at 8 a.m. ET Nov. 3, ahead of an expected regulatory ...

Recursive Superintelligence released the open-weight model Flint-40B-A2B on October 21, a mixture-of-experts model with roughly 39.8 billion ...

Recursive released Flint, a 40-billion-parameter open-weight coding model built to run offline on-device; the company says it tops 125 tokens per second on an M4 Pro MacBook Pro. · 14 sources across ...

Read about Recursive’s Flint AI coding model, its laptop-friendly design, coding benchmarks, open-source license, and Eureka ...

Recursive released Flint Oct. 21, 2026: a 40B MoE coding model with 2.5B active params, Apache 2.0, free on OpenRouter.

Recursion Pharmaceuticals (RXRX) just moved onto many investors’ radar after Sanofi optioned the first development candidate from their collaboration, triggering a US$10 million milestone payment and ...